DA
Andrey, Diego Olivier
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Synergistic activity of a KL51-depolymerase and a Sugarlandvirus bacteriophage against ST16 Klebsiella pneumoniae | Microbiology spectrum |  | 2025 | 5 | 4 | ||
| Klebsiella pneumoniae : ombre et lumière | Revue médicale suisse |  | 2025 | 18 | 1 | ||
| Horizontal transmission of a multidrug-resistant IncM1 plasmid harbouring blaOXA-48 and blaCTX-M-14b among patient microbiotas | Journal of antimicrobial chemotherapy | | 2025 | 40 | 26 | ||
| Genomic characterization of plasmids harboring blaNDM-1, blaNDM-5, and blaNDM-7 carbapenemase alleles in clinical Klebsiella pneumoniae in Pakistan | Microbiology spectrum | | 2025 | 42 | 13 | ||
| A framework towards implementation of sequencing for antimicrobial-resistant and other health-care-associated pathogens | The Lancet. Infectious diseases | | 2025 | 77 | 0 | ||
| Association of pathogenic determinants of Fusobacterium necrophorum with bacteremia, and Lemierre’s syndrome | Scientific reports | | 2024 | 78 | 73 | ||
| Contributions of long-read sequencing for the detection of antimicrobial resistance | Pathogens | | 2024 | 251 | 190 | ||
| In-vitro activity of the novel β-lactam/β-lactamase inhibitor combinations and cefiderocol against carbapenem-resistant Pseudomonas spp. clinical isolates collected in Switzerland in 2022 | European journal of clinical microbiology & infectious diseases | | 2024 | 54 | 92 | ||
| Molecular analysis of metallo-beta-lactamase-producing Pseudomonas aeruginosa in Switzerland 2022–2023 | European journal of clinical microbiology & infectious diseases | | 2024 | 50 | 86 | ||
| Antibiotics’ collateral effects on the gut microbiota in the selection of ESKAPE pathogens | CMI communications | | 2024 | 63 | 97 | ||
| Entérobactéries multirésistantes et voyage | Revue médicale suisse | | 2024 | 87 | 4 | ||
| Mediastinitis caused by an NDM-1 Escherichia coli in a child with Dacron® Sano shunt after pulmonary atresia with ventricular septal defect surgery treated with combination of aztreonam-avibactam | International journal of antimicrobial agents | | 2024 | 70 | 43 | ||
| Potent in-vitro activity of sulbactam-durlobactam against NDM-producing Escherichia coli including cefiderocol and aztreonam-avibactam-resistant isolates | Clinical microbiology and infection | | 2024 | 94 | 1 | ||
| Carriage of third-generation cephalosporin-resistant and carbapenem-resistant Enterobacterales among children in sub-Saharan Africa : a systematic review and meta-analysis | EClinicalMedicine | | 2024 | 128 | 59 | ||
| Synergistic effects of ceftazidime/avibactam combined with meropenem in a murine model of infection with KPC-producing Klebsiella pneumoniae | Journal of antimicrobial chemotherapy | | 2024 | 84 | 7 | ||
| Antimicrobial resistance in Enterobacterales infections among children in sub-Saharan Africa : a systematic review and meta-analysis | EClinicalMedicine | | 2024 | 102 | 234 | ||
| Lecture de l’antibiogramme dans un contexte de résistance aux antibiotiques | Revue médicale suisse | | 2023 | 84 | 354 | ||
| Antibiotic heteroresistance in ESKAPE pathogens, from bench to bedside | Clinical microbiology and infection | | 2023 | 76 | 164 | ||
| Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide origin | Journal of global antimicrobial resistance | | 2023 | 84 | 148 | ||
| Antimicrobial resistance dissemination driven by Klebsiella pneumoniae: the role of high-risk clones and high-risk plasmids | | 2023 | 121 | 206 | |||
| Characterization of Amino Acid Substitution W20S in MgrB Involved in Polymyxin Resistance in Klebsiella pneumoniae | Microbiology spectrum | | 2022 | 119 | 185 | ||
| Changes in the gut bacterial communities in colon cancer surgery patients: an observational study | Gut pathogens | | 2022 | 222 | 106 | ||
| Silent circulation of BKC-1-producing Klebsiella pneumoniae ST442: molecular and clinical characterization of an early and unreported outbreak | International journal of antimicrobial agents | | 2022 | 92 | 78 | ||
| Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 84 | 0 | |||
| Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | | 2022 | 225 | 35 | ||
| Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | | 2022 | 439 | 127 | ||
| Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases | Frontiers in immunology | | 2022 | 201 | 58 | ||
| Epidemiology and outcomes of bone and joint infections in solid organ transplant recipients | American journal of transplantation | | 2022 | 240 | 102 | ||
| Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | | 2021 | 521 | 306 | ||
| Prevalence of immunoglobulin G (IgG) against severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) andeEvaluation of a rapid MEDsan IgG test in children seeking medical care | Clinical Infectious Diseases | | 2021 | 297 | 218 | ||
| Persistence of anti-SARS-CoV-2 antibodies: immunoassay heterogeneity and implications for serosurveillance | Clinical Microbiology and Infection | | 2021 | 299 | 256 | ||
| Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | | 2021 | 403 | 200 | ||
| A high-throughput microfluidic nanoimmunoassay for detecting anti–SARS-CoV-2 antibodies in serum or ultralow-volume blood samples | Proceedings of the National Academy of Sciences | | 2021 | 344 | 220 | ||
| Post-exposure Lopinavir-Ritonavir Prophylaxis versus Surveillance for Individuals Exposed to SARS-CoV-2: The COPEP Pragmatic Open-Label, Cluster Randomized Trial | EClinicalMedicine | | 2021 | 637 | 145 | ||
| Vertical and horizontal dissemination of an incC plasmid harbouring rmtb 16s rRNA methylase gene, conferring resistance to plazomicin, among invasive ST258 and ST16 KPC-producing Klebsiella pneumoniae | Journal of global antimicrobial resistance | | 2021 | 255 | 198 | ||
| Head-to-head evaluation of five automated SARS-CoV-2 serology immunoassays in various prevalence settings | Journal of Clinical Medicine | | 2021 | 338 | 175 | ||
| A new mutation in mgrb mediating polymyxin resistance in Klebsiella variicola | International journal of antimicrobial agents | | 2021 | 85 | 218 | ||
| Diagnostic accuracy of Augurix COVID-19 IgG serology rapid test | European Journal of Clinical Investigation | | 2020 | 453 | 386 | ||
| An Emerging Clone, Klebsiella pneumoniae Carbapenemase 2–Producing K. pneumoniae Sequence Type 16, Associated With High Mortality Rates in a CC258-Endemic Setting | Clinical infectious diseases | | 2020 | 100 | 53 | ||
| Head-to-head accuracy comparison of three commercial COVID-19 IgM/IgG serology rapid tests | Journal of Clinical Medicine | | 2020 | 377 | 191 | ||
| Insights into the global effect on Staphylococcus aureus growth arrest by induction of the endoribonuclease MazF toxin | Nucleic Acids Research | | 2020 | 440 | 276 | ||
| Efficacy of pragmatic same-day ring prophylaxis for adult individuals exposed to SARS-CoV-2 in Switzerland (COPEP): protocol of an open-label cluster randomised trial | BMJ Open | | 2020 | 266 | 103 | ||
| Clinical and Molecular Description of a High-Copy IncQ1 KPC-2 Plasmid Harbored by the International ST15 Klebsiella pneumoniae Clone | mSphere | | 2020 | 203 | 280 | ||
| Pancreas preservation fluid microbial contamination is associated with poor islet isolation outcomes - a multi centre cohort study | Transplant International | | 2018 | 530 | 363 | ||
| Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals | European Journal of Clinical Microbiology & Infectious Diseases | | 2017 | 676 | 236 | ||
| Cerebral Rhizomucor Infection Treated by Posaconazole Delayed-Release Tablets in an Allogeneic Stem Cell Transplant Recipient | International journal of infectious diseases | | 2017 | 612 | 162 | ||
| Rifampin Resistance rpoB Alleles or Multicopy Thioredoxin/Thioredoxin Reductase Suppresses the Lethality of Disruption of the Global Stress Regulator spx in Staphylococcus aureus | Journal of bacteriology | | 2016 | 620 | 1 | ||
| Re-emergence of scarlet fever: old players return? | Expert review of anti-infective therapy | | 2016 | 494 | 1 | ||
| Clinical and epidemiological differences between implant-associated and implant-free orthopaedic infections | European journal of orthopaedic surgery & traumatology | | 2016 | 550 | 0 | ||
| Xpert(®) MTB/RIF assay sensitivity with different methods of CSF processing for the diagnosis of TB meningitis | The international journal of tuberculosis and lung disease | | 2015 | 524 | 392 | ||
| Impact of the Regulators SigB, Rot, SarA and sarS on the Toxic Shock Tst Promoter and TSST-1 Expression in Staphylococcus aureus | PloS one | | 2015 | 665 | 545 | ||
| The posttranslocational chaperone lipoprotein PrsA is involved in both glycopeptide and oxacillin resistance in Staphylococcus aureus | Antimicrobial agents and chemotherapy | | 2012 | 749 | 461 | ||
| Site-specific mutation of Staphylococcus aureus VraS reveals a crucial role for the VraR-VraS sensor in the emergence of glycopeptide resistance | Antimicrobial agents and chemotherapy | | 2011 | 725 | 0 | ||
| Molecular regulation of tst superantigen expression by global regulatory systems in Staphylococcus aureus | | 2011 | 769 | 903 | |||
| Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus | PloS one | | 2011 | 700 | 614 | ||
| Coordinated regulation by AgrA, SarA, and SarR to control agr expression in Staphylococcus aureus | Journal of bacteriology | | 2011 | 626 | 1 | ||
| Control of the Staphylococcus aureus toxic shock tst promoter by the global regulator SarA | Journal of bacteriology | | 2010 | 657 | 0 | ||
| Use of serum antistreptolysin O titers in the microbial diagnosis of orthopedic infections | International journal of infectious diseases | | 2009 | 646 | 0 |
